Orange Book product · Brand (NDA)
ANCOBON
FLUCYTOSINE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
FLUCYTOSINE
Strength
500MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 017001
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025FLUCYTOSINEGeneric (ANDA)
ANDA 218005 · LAURUS
- 2020FLUCYTOSINEGeneric (ANDA)
ANDA 213665 · AUROBINDO PHARMA LTD
- 2020FLUCYTOSINEGeneric (ANDA)
ANDA 212632 · STRIDES PHARMA
- 2018FLUCYTOSINEGeneric (ANDA)
ANDA 207536 · STRIDES PHARMA
- 2017FLUCYTOSINEGeneric (ANDA)
ANDA 206550 · HIKMA
- 2017FLUCYTOSINEGeneric (ANDA)
ANDA 204652 · NOVEL LABS INC
- 2011FLUCYTOSINEGeneric (ANDA)
ANDA 201566 · SIGMAPHARM LABS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
